Sunday , April 5 2020
Home / canada / Warning Health Canada drugs are not consistent with other countries: report – The National

Warning Health Canada drugs are not consistent with other countries: report – The National



[ad_1]

Health Canada needs to be more consistent with the three other countries, when it comes to issuing warnings about the security risks of certain medications, especially when jurisdictions with similar demographics have advised the patient to take the same medicine, says University of British Columbia professor.

Barbara Mintzes, lead researcher of the new study, released Monday, says that between 2007 and 2016, Health Canada issued a safety warning only 50 percent of drug safety issues identified in the United States, Australia and the UK.

She joined the researchers in analyzing the 1441 recommendation during this period and found the controls in all four countries were consistent only in the decision to warn their population 10 percent of the time in relation to matters with the same drug.

Compared with other countries, Health Canada issued a recommendation only 317 of the 635 drug-risk issues, or nearly 50 percent of the problems with the risk of drug identified by the US Food and Drug Administration, the UK Medicines and Healthcare products Regulatory Agency and the Australian Therapeutic goods administration, the study said.

READ MORE:
Canada expands recall of blood pressure drugs, to include more drugs valsartan

The study was published in JAMA Internal Medicine, published by the American Medical Association, and also includes researchers from York University in Toronto and the University of Sydney in Australia.

Health Canada issues warning on its website, and Mintzes said he will also send letters to doctors who prescribed drugs.

"Some of the security warnings put out by Health Canada, in cooperation with the manufacturer, and that will come as individually sent a letter to every doctor in the specialty or … a wider set of all physicians practicing in Canada," said Mintzes, which is a & # 39; He is an assistant professor in the UBC school branch in the field of population and public health.

She said that in January 2013, Health Canada issued a warning about the often designed to lower cholesterol drug levels, or statins, are associated with an increased risk of diabetes in patients already at risk for the disease.

However, the warning was issued in the year after the United States and Australia have informed the patients about medicines following major studies that show a link with diabetes, she said.

"Why is Health Canada to wait another year after the warning occurred in the US and Australia?" Asked Mintzes, who is also with the & # 39 is on & # 39; yunkt professor at the University of Sydney.

The department said he regularly interacts with key international partners, including, in addition to the United States, Australia and the European Union to determine whether there are any new safety concerns. After becoming aware of any potential problems, the assessment is done to determine when such a risk with the & # 39 is warranted in Canada.

READ MORE:
Ontario mom wants mandatory prescription-error reporting in Canada after son, 8, dies

"Timing and content of risk communication may vary in different countries for a variety of reasons, including, for example, as the product is used in Canada," the statement said.

Health Canada needs to be more transparent information on which it bases its warning, especially because clinical and clinical trial data that were previously confidential have been publicly available for some time after a similar position in the European Union, Mintzes said.

READ MORE:
Is it safe to take medication during pregnancy?

"We could do more as a nation to have more services available to people who use drugs, with user-friendly website, which provides information to the public, so they can simply watch their preparation is quite easy."

Pharmacies in Canada are also inconsistencies in the provision of written information to patients about medications and possible side effects, added Mintzes.

"We must have the right to legislate always endorsing the patient information provided to us every time we have a prescription dispensed."

A study conducted in 2013 of the Canadian Institute for Health Information said up to a quarter of patients visiting the emergency room because of adverse reactions to the hospital and the elderly at higher risk for such effects.

Antibiotics & # 39 are among the most common drug-related adverse reactions which are known to be affected by such factors as the number of medicines a patient is taking, according to the study.

[ad_2]
Source link